WeChat Mini Program
Old Version Features

Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2)

Ian Benjamin Gaddie,Eric D. Donnenfeld,Paul Karpecki,Patrick Vollmer,Gregg J. Berdy, Jared D. Peterson, Aimee R. P. Edell,Blake Simmons, William E. Whitson,Joseph B. Ciolino,Stephanie N. Baba,Mark Holdbrook, Jose Trevejo,John Meyer,Elizabeth Yeu

OPHTHALMOLOGY（2023）

Cited 15|Views15
Key words
Blepharitis,Demodex blepharitis,Lotilaner ophthalmic solution 0.25%,Lotilaner phase 3 clinical trial,Treatment of Demodex blepharitis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined